NCT00040937 S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00039754 A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT00038818 CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation Status TERMINATED Phase NA
NCT00037791 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Status COMPLETED Phase PHASE3
NCT00036140 Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00036023 Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies Status COMPLETED Phase PHASE2
NCT00029224 Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions Status COMPLETED Phase PHASE4
NCT00028600 Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00024466 Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT00012350 Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00006184 Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00005834 S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma Status TERMINATED Phase PHASE3
NCT00005792 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00003511 Antineoplaston Therapy in Treating Patients With Multiple Myeloma Status TERMINATED Phase PHASE2